Literature DB >> 1712766

Revised NMR assignments for rapamycin.

J B McAlpine, S J Swanson, M Jackson, D N Whittern.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1712766     DOI： 10.7164/antibiotics.44.688

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

Review 1.  Microbial natural products: molecular blueprints for antitumor drugs.

Authors:  Lesley-Ann Giddings; David J Newman
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-03       Impact factor: 3.346

2.  The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin.

Authors:  T Schwecke; J F Aparicio; I Molnár; A König; L E Khaw; S F Haydock; M Oliynyk; P Caffrey; J Cortés; J B Lester
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

3.  Hemiacetal-less rapamycin derivatives designed and produced by genetic engineering of a type I polyketide synthase.

Authors:  Kei Kudo; Takehiro Nishimura; Ikuko Kozone; Junko Hashimoto; Noritaka Kagaya; Hikaru Suenaga; Haruo Ikeda; Kazuo Shin-Ya
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

4.  Mutational biosynthesis of novel rapamycins by a strain of Streptomyces hygroscopicus NRRL 5491 disrupted in rapL, encoding a putative lysine cyclodeaminase.

Authors:  L E Khaw; G A Böhm; S Metcalfe; J Staunton; P F Leadlay
Journal:  J Bacteriol       Date:  1998-02       Impact factor: 3.490

Review 5.  Cancer wars: natural products strike back.

Authors:  Christine Basmadjian; Qian Zhao; Embarek Bentouhami; Amel Djehal; Canan G Nebigil; Roger A Johnson; Maria Serova; Armand de Gramont; Sandrine Faivre; Eric Raymond; Laurent G Désaubry
Journal:  Front Chem       Date:  2014-05-01       Impact factor: 5.221
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.